ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of its ...
Eli Lilly and Company has announced topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial.
Eli Lilly said it would invest $3 billion to expand a recently acquired manufacturing facility to meet growing demand for its diabetes and weight-loss medicines.
Given the scale of the NHS's problems, from waiting times at record levels to overloaded A&E units, you might have thought it ...
Lilly’s blockbuster weight-loss and diabetes drugs have made it the most valuable pharmaceutical company in the world.
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it ...
The U.K. will start offering Eli Lilly’s weight loss drug next year, but will restrict the medicine to people with the ...
The new generation of weight-loss drugs were initially developed to treat diabetes and work by mimicking a hormone that ...
What is Mounjaro and how does the weight-loss jab work? - Eligible people may have to wait years for the ‘King Kong of weight ...
Unsurprisingly, these stock pickers are capitalizing on an opportunity that's only recently become addressable.